Novo Nordisk A/S (NVO) Dividend Payout Ratio: 42.14%
Is Novo Nordisk A/S’s dividend payout ratio high or low?
Novo Nordisk A/S's dividend payout ratio of 42.14% is in line with its 5-year average of 46.62%, around the middle of its 5-year range (15.88%–80.64%).
As of Wednesday, June 17, 2026. 13.60% below its 12-month average of 48.78%.
Dividend Payout Ratio (42.14%) = TTM Dividends/Share ($1.80) / TTM EPS ($4.28)
NVO Dividend Payout Ratio Chart
NVO Average Dividend Payout Ratio Chart
NVO Current vs Average Dividend Payout Ratio Chart
NVO Dividend Payout Ratio Metrics
DIVIDEND PAYOUT RATIO
42.14%
DIVIDEND PAYOUT RATIO AVG TTM
48.78%
DIVIDEND PAYOUT RATIO AVG 3Y
46.34%
DIVIDEND PAYOUT RATIO AVG 5Y
47.63%
DIVIDEND PAYOUT RATIO AVG 10Y
48.30%
DIVIDEND PAYOUT RATIO AVG 15Y
45.66%
DIVIDEND PAYOUT RATIO AVG 20Y
42.82%
CURRENT VS TTM AVG
-13.60%
CURRENT VS 3Y AVG
-9.05%
CURRENT VS 5Y AVG
-11.52%
CURRENT VS 10Y AVG
-12.74%
CURRENT VS 15Y AVG
-7.70%
CURRENT VS 20Y AVG
-1.59%
Annual Payout Ratio History
| Year | EPS | Dividend | Payout Ratio |
|---|---|---|---|
| 2025 | $3.62 | $1.73 | 47.7% |
| 2024 | $3.14 | $1.45 | 46.1% |
| 2023 | $2.76 | $1.03 | 37.2% |
| 2022 | $1.76 | $0.80 | 45.5% |
| 2021 | $1.59 | $0.74 | 46.3% |
| 2020 | $1.48 | $0.65 | 44.0% |
| 2019 | $1.23 | $0.61 | 49.9% |
| 2018 | $1.23 | $0.63 | 51.7% |
| 2017 | $1.24 | $0.57 | 46.1% |
| 2016 | $1.06 | $0.71 | 66.6% |
| 2015 | $0.99 | $0.36 | 37.0% |
| 2014 | $0.82 | $0.42 | 50.6% |
| 2013 | $0.87 | $0.31 | 35.8% |
| 2012 | $0.69 | $0.25 | 36.4% |
| 2011 | $0.53 | $0.19 | 35.8% |
| 2010 | $0.44 | $0.14 | 30.6% |
| 2009 | $0.35 | $0.11 | 31.4% |
| 2008 | $0.29 | $0.09 | 32.3% |
| 2007 | $0.26 | $0.06 | 23.5% |
| 2006 | $0.18 | $0.05 | 27.2% |
| 2005 | $0.14 | $0.04 | 30.3% |
| 2004 | $0.14 | $0.04 | 26.5% |
| 2003 | $0.12 | $0.03 | 21.8% |
| 2002 | $0.09 | $0.02 | 20.9% |
| 2001 | $0.09 | $0.02 | 17.5% |
| 2000 | $0.07 | $0.01 | 17.2% |
| 1999 | $0.05 | $0.01 | 20.4% |
| 1998 | $0.05 | $0.01 | 11.5% |
| 1997 | $0.05 | $0.01 | 12.2% |
| 1996 | $0.04 | $0.00 | 11.0% |
Novo Nordisk A/S Dividend Payout Ratio Formula & Definition
The payout ratio shows the share of trailing-12-month earnings paid out as dividends. Lower leaves more room to grow the dividend; a ratio persistently above 100% means dividends exceed earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Novo Nordisk A/S Dividend Payout Ratio FAQ
- What is the dividend payout ratio for Novo Nordisk A/S (NVO)?
- The dividend payout ratio for NVO stock is 42.14%.
- Is Novo Nordisk A/S's dividend payout ratio high or low?
- Novo Nordisk A/S's dividend payout ratio of 42.14% is in line with its 5-year average of 46.62%, around the middle of its 5-year range (15.88%–80.64%).
- What is the TTM average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The TTM average dividend payout ratio for NVO stock is 48.78%.
- What is the 3Y average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The 3Y average dividend payout ratio for NVO stock is 46.34%.
- What is the 5Y average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The 5Y average dividend payout ratio for NVO stock is 47.63%.
- What is the 10Y average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The 10Y average dividend payout ratio for NVO stock is 48.30%.
- What is the 15Y average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The 15Y average dividend payout ratio for NVO stock is 45.66%.
- What is the 20Y average dividend payout ratio for Novo Nordisk A/S (NVO)?
- The 20Y average dividend payout ratio for NVO stock is 42.82%.
Novo Nordisk A/S Dividend Payout Ratio History
| DATE | DIVIDEND PAYOUT RATIO |
|---|---|
| 2026-06-17 | 42.14% |
| 2026-06-15 | 42.13% |
| 2026-06-11 | 42.13% |
| 2026-06-09 | 42.15% |
| 2026-06-05 | 42.15% |
| 2026-06-03 | 42.17% |
| 2026-06-01 | 42.15% |
| 2026-05-28 | 42.16% |
| 2026-05-26 | 42.16% |
| 2026-05-21 | 42.13% |
| 2026-05-19 | 42.15% |
| 2026-05-15 | 42.16% |
| 2026-05-13 | 42.13% |
| 2026-05-11 | 42.17% |
| 2026-05-07 | 42.13% |
| 2026-05-05 | 50.91% |
| 2026-05-01 | 50.91% |
| 2026-04-29 | 50.93% |
| 2026-04-27 | 50.90% |
| 2026-04-23 | 50.94% |
| 2026-04-21 | 50.92% |
| 2026-04-17 | 50.91% |
| 2026-04-15 | 50.90% |
| 2026-04-13 | 50.90% |
| 2026-04-09 | 50.91% |
| 2026-04-07 | 50.91% |
| 2026-04-02 | 50.91% |
| 2026-03-31 | 50.94% |
| 2026-03-27 | 48.83% |
| 2026-03-25 | 48.82% |
| 2026-03-23 | 48.82% |
| 2026-03-19 | 48.81% |
| 2026-03-17 | 48.80% |
| 2026-03-13 | 48.81% |
| 2026-03-11 | 48.79% |
| 2026-03-09 | 48.79% |
| 2026-03-05 | 48.80% |
| 2026-03-03 | 48.80% |
| 2026-02-27 | 48.79% |
| 2026-02-25 | 48.78% |
| 2026-02-23 | 48.80% |
| 2026-02-19 | 48.79% |
| 2026-02-17 | 48.79% |
| 2026-02-12 | 48.81% |
| 2026-02-10 | 48.80% |
| 2026-02-06 | 48.79% |
| 2026-02-04 | 48.82% |
| 2026-02-02 | 49.82% |
| 2026-01-29 | 49.80% |
| 2026-01-27 | 49.81% |
| 2026-01-23 | 49.81% |
| 2026-01-21 | 49.81% |
| 2026-01-16 | 49.81% |
| 2026-01-14 | 49.80% |
| 2026-01-12 | 49.82% |
| 2026-01-08 | 49.81% |
| 2026-01-06 | 49.82% |
| 2026-01-02 | 49.81% |
| 2025-12-30 | 49.80% |
| 2025-12-26 | 49.83% |
| 2025-12-23 | 49.82% |
| 2025-12-19 | 49.81% |
| 2025-12-17 | 49.81% |
| 2025-12-15 | 49.81% |
| 2025-12-11 | 49.83% |
| 2025-12-09 | 49.80% |
| 2025-12-05 | 49.83% |
| 2025-12-03 | 49.81% |
| 2025-12-01 | 49.81% |
| 2025-11-26 | 49.81% |
| 2025-11-24 | 49.81% |
| 2025-11-20 | 49.81% |
| 2025-11-18 | 49.83% |
| 2025-11-14 | 49.81% |
| 2025-11-12 | 49.82% |
| 2025-11-10 | 49.81% |
| 2025-11-06 | 49.83% |
| 2025-11-04 | 46.99% |
| 2025-10-31 | 47.00% |
| 2025-10-29 | 47.00% |
| 2025-10-27 | 46.98% |
| 2025-10-23 | 47.01% |
| 2025-10-21 | 47.00% |
| 2025-10-17 | 47.01% |
| 2025-10-15 | 47.01% |
| 2025-10-13 | 47.00% |
| 2025-10-09 | 47.00% |
| 2025-10-07 | 46.99% |
| 2025-10-03 | 47.00% |
| 2025-10-01 | 46.99% |
| 2025-09-29 | 46.98% |
| 2025-09-25 | 46.99% |
| 2025-09-23 | 46.99% |
| 2025-09-19 | 47.00% |
| 2025-09-17 | 47.00% |
| 2025-09-15 | 47.01% |
| 2025-09-11 | 47.00% |
| 2025-09-09 | 47.00% |
| 2025-09-05 | 46.99% |
| 2025-09-03 | 46.99% |
| 2025-08-29 | 47.01% |
| 2025-08-27 | 47.00% |
| 2025-08-25 | 46.99% |
| 2025-08-21 | 46.99% |
| 2025-08-19 | 47.00% |
| 2025-08-15 | 45.15% |
| 2025-08-13 | 45.15% |
| 2025-08-11 | 45.16% |
| 2025-08-07 | 45.16% |
| 2025-08-05 | 49.06% |
| 2025-08-01 | 49.07% |
| 2025-07-30 | 49.06% |
| 2025-07-28 | 49.06% |
| 2025-07-24 | 49.06% |
| 2025-07-22 | 49.08% |
| 2025-07-18 | 49.05% |
| 2025-07-16 | 49.06% |
| 2025-07-14 | 49.06% |
| 2025-07-10 | 49.08% |
| 2025-07-08 | 49.06% |
| 2025-07-03 | 49.06% |
| 2025-07-01 | 49.06% |
| 2025-06-27 | 49.07% |
| 2025-06-25 | 49.06% |
| 2025-06-23 | 49.06% |
| 2025-06-18 | 49.06% |
| 2025-06-16 | 49.06% |
| 2025-06-12 | 49.06% |
| 2025-06-10 | 49.07% |
| 2025-06-06 | 49.07% |
| 2025-06-04 | 49.07% |
| 2025-06-02 | 49.06% |
| 2025-05-29 | 49.07% |
| 2025-05-27 | 49.07% |
| 2025-05-22 | 49.08% |
| 2025-05-20 | 49.08% |
| 2025-05-16 | 49.06% |
| 2025-05-14 | 49.05% |
| 2025-05-12 | 49.07% |
| 2025-05-08 | 49.05% |
| 2025-05-06 | 50.97% |
| 2025-05-02 | 50.98% |
| 2025-04-30 | 50.97% |
| 2025-04-28 | 50.99% |
| 2025-04-24 | 50.98% |
| 2025-04-22 | 50.97% |
| 2025-04-17 | 50.97% |
| 2025-04-15 | 50.98% |
| 2025-04-11 | 50.97% |
| 2025-04-09 | 50.96% |
| 2025-04-07 | 50.98% |
| 2025-04-03 | 50.97% |
| 2025-04-01 | 50.98% |
| 2025-03-28 | 15.88% |
| 2025-03-26 | 15.88% |
| 2025-03-24 | 15.88% |
| 2025-03-20 | 44.42% |
| 2025-03-18 | 44.42% |
| 2025-03-14 | 44.43% |
| 2025-03-12 | 44.42% |
| 2025-03-10 | 44.42% |
| 2025-03-06 | 44.42% |
| 2025-03-04 | 44.43% |
| 2025-02-28 | 44.43% |
| 2025-02-26 | 44.43% |
| 2025-02-24 | 44.43% |
| 2025-02-20 | 44.42% |
| 2025-02-18 | 44.43% |
| 2025-02-13 | 44.42% |
| 2025-02-11 | 44.42% |
| 2025-02-07 | 44.43% |
| 2025-02-05 | 44.42% |
| 2025-02-03 | 46.56% |
| 2025-01-30 | 46.55% |
| 2025-01-28 | 46.57% |
| 2025-01-24 | 46.56% |
| 2025-01-22 | 46.56% |
| 2025-01-17 | 46.55% |
| 2025-01-15 | 46.55% |
| 2025-01-13 | 46.56% |
| 2025-01-08 | 46.56% |
| 2025-01-06 | 46.55% |
| 2025-01-02 | 46.57% |
| 2024-12-30 | 46.56% |
| 2024-12-26 | 46.56% |
| 2024-12-23 | 46.56% |
| 2024-12-19 | 46.56% |
| 2024-12-17 | 46.56% |
| 2024-12-13 | 46.56% |
| 2024-12-11 | 46.56% |
| 2024-12-09 | 46.56% |
| 2024-12-05 | 46.56% |
| 2024-12-03 | 46.57% |
| 2024-11-29 | 46.56% |
| 2024-11-26 | 46.56% |
| 2024-11-22 | 46.56% |
| 2024-11-20 | 46.56% |
| 2024-11-18 | 46.56% |
| 2024-11-14 | 46.56% |
| 2024-11-12 | 46.56% |
| 2024-11-08 | 46.56% |
| 2024-11-06 | 46.56% |
| 2024-11-04 | 46.56% |
| 2024-10-31 | 46.56% |
| 2024-10-29 | 46.56% |
| 2024-10-25 | 46.56% |
| 2024-10-23 | 46.56% |
| 2024-10-21 | 46.56% |
| 2024-10-17 | 46.56% |
| 2024-10-15 | 46.56% |
| 2024-10-11 | 46.57% |
| 2024-10-09 | 46.56% |
| 2024-10-07 | 46.55% |
| 2024-10-03 | 46.56% |
| 2024-10-01 | 46.56% |
| 2024-09-27 | 49.87% |
| 2024-09-25 | 49.87% |
| 2024-09-23 | 49.88% |
| 2024-09-19 | 49.87% |
| 2024-09-17 | 49.87% |
| 2024-09-13 | 49.87% |
| 2024-09-11 | 49.87% |
| 2024-09-09 | 49.87% |
| 2024-09-05 | 49.88% |
| 2024-09-03 | 49.87% |
| 2024-08-29 | 49.87% |
| 2024-08-27 | 49.88% |
| 2024-08-23 | 49.87% |
| 2024-08-21 | 49.87% |
| 2024-08-19 | 49.87% |
| 2024-08-15 | 47.16% |
| 2024-08-13 | 47.16% |
| 2024-08-09 | 47.16% |
| 2024-08-07 | 47.15% |
| 2024-08-05 | 47.16% |
| 2024-08-01 | 47.16% |
| 2024-07-30 | 47.15% |
| 2024-07-26 | 47.16% |
| 2024-07-24 | 47.16% |
| 2024-07-22 | 47.16% |
| 2024-07-18 | 47.16% |
| 2024-07-16 | 47.16% |
| 2024-07-12 | 47.15% |
| 2024-07-10 | 47.15% |
| 2024-07-08 | 47.16% |
| 2024-07-03 | 47.16% |
| 2024-07-01 | 47.16% |
| 2024-06-27 | 47.41% |
| 2024-06-25 | 47.41% |
| 2024-06-21 | 47.40% |
| 2024-06-18 | 47.41% |
| 2024-06-14 | 47.41% |
| 2024-06-12 | 47.40% |
| 2024-06-10 | 47.41% |
| 2024-06-06 | 47.41% |
| 2024-06-04 | 47.41% |
| 2024-05-31 | 47.41% |
| 2024-05-29 | 47.41% |
| 2024-05-24 | 47.41% |
| 2024-05-22 | 47.40% |
Showing the most recent 260 of 2,510 data points. The chart above shows the full history.
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar